Tumor lysis syndrome causes: Difference between revisions
Nazia Fuad (talk | contribs) No edit summary |
Nazia Fuad (talk | contribs) |
||
(3 intermediate revisions by the same user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Development of tumor lysis syndrome is the result of initiation of [[chemotherapy]] or [[radiotherapy]] in cancer patients and | Development of tumor lysis syndrome is the result of initiation of [[chemotherapy]] or [[radiotherapy]] in cancer patients. The most common causes of tumor lysis syndrome are [[Burkitt's lymphoma]][[Acute lymphoblastic leukemia|, acute lymphoblastic leukemia]][[Acute myeloid leukemia|, acute myeloid leukemia]] and [[chemotherapy]] including [[methotrexate]]. Sometimes it can occur spontaneously without administration of treatment primarily in patients with non-Hodgkin lymphoma (NHL) or acute leukemia. | ||
==Causes== | ==Causes== | ||
===Common Causes=== | ===Common Causes=== | ||
The most common causes of tumor lysis syndrome are:<ref name="urlwww.asn-online.org">{{cite web |url=https://www.asn-online.org/education/distancelearning/curricula/onco/Chapter4.pdf |title=www.asn-online.org |format= |work= |accessdate=}}</ref><ref name="pmid21561350">{{cite journal |vauthors=Howard SC, Jones DP, Pui CH |title=The tumor lysis syndrome |journal=N. Engl. J. Med. |volume=364 |issue=19 |pages=1844–54 |date=May 2011 |pmid=21561350 |pmc=3437249 |doi=10.1056/NEJMra0904569 |url=}}</ref> | |||
*[[Burkitt's lymphoma]] | *[[Burkitt's lymphoma]] | ||
*[[Acute lymphoblastic leukemia]] | *[[Acute lymphoblastic leukemia]] | ||
*[[Acute myeloid leukemia]] | *[[Acute myeloid leukemia]] | ||
*[[Chemotherapy]] including [[methotrexate]] | *[[Chemotherapy]] including [[methotrexate]] | ||
=== Less common causes === | |||
* Solid tumor | |||
* [[Myeloma]] | |||
* [[Chronic leukemia|Chronic myeloid leukemia CML]] | |||
* CLL [[chronic lymphocytic leukemia]] | |||
* [[Hodgkin lymphoma]] | |||
* [[Small lymphocytic lymphoma]] | |||
* [[Marginal zone lymphoma|Marginal zone B cell]] | |||
* [[MALT lymphoma|MALT]] | |||
* Nonblastoid mantle cell | |||
* [[Cutaneous T cell lymphoma|Cutaneous T cell]] | |||
* [[Adult T-cell leukemia]] | |||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
{|style="width:80%; height:100px" border="1" | {| style="width:80%; height:100px" border="1" | ||
| | | style="width:25%" bgcolor="LightSteelBlue" ; border="1" |'''Cardiovascular''' | ||
| | | style="width:75%" bgcolor="Beige" ; border="1" | No underlying causes | ||
|- | |- | ||
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | | bgcolor="LightSteelBlue" | '''Chemical/Poisoning''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Dental''' | | '''Dental''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| | | bgcolor="Beige" | | ||
[[Bortezomib]], | [[Bortezomib]], | ||
[[Carfilzomib]], | [[Carfilzomib]], | ||
Line 43: | Line 57: | ||
[[Ibrutinib]], | [[Ibrutinib]], | ||
[[imatinib]], | [[imatinib]], | ||
[[lenalidomide ]], | [[lenalidomide ]] , | ||
[[Nelarabine]], | [[Nelarabine]], | ||
[[Nilotinib]], | [[Nilotinib]], | ||
Line 54: | Line 68: | ||
[[zoledronic acid]] | [[zoledronic acid]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Ear Nose Throat''' | | '''Ear Nose Throat''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Environmental''' | | '''Environmental''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal/Orthopedic''' | | '''Musculoskeletal/Orthopedic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Oncologic''' | | '''Oncologic''' | ||
|bgcolor="Beige"| | | bgcolor="Beige" | | ||
[[Acute lymphoblastic leukemia ]], | [[Acute lymphoblastic leukemia ]] , | ||
[[acute myeloid leukemia]], | [[acute myeloid leukemia]], | ||
[[adult T-cell leukemia/lymphoma ]], | [[adult T-cell leukemia/lymphoma ]] , | ||
[[anaplastic large cell lymphoma]], | [[anaplastic large cell lymphoma]], | ||
[[breast cancer ]], | [[breast cancer ]] , | ||
[[Burkitt's lymphoma]], | [[Burkitt's lymphoma]], | ||
[[chronic myeloid leukemia]], | [[chronic myeloid leukemia]], | ||
[[diffuse large B-cell lymphoma]], | [[diffuse large B-cell lymphoma]], | ||
[[gastrointestinal stromal tumors]], | [[gastrointestinal stromal tumors]], | ||
[[germ cell tumors ]], | [[germ cell tumors ]] , | ||
[[hepatoblastoma]], | [[hepatoblastoma]], | ||
[[hepatocellular carcinoma]], | [[hepatocellular carcinoma]], | ||
Line 121: | Line 135: | ||
[[medulloblastoma]], | [[medulloblastoma]], | ||
[[melanoma]], | [[melanoma]], | ||
[[Colorectal cancer|metastatic colorectal cancer ]], | [[Colorectal cancer|metastatic colorectal cancer]] , | ||
[[multiple myeloma]], | [[multiple myeloma]], | ||
[[neuroblastoma]], | [[neuroblastoma]], | ||
[[Non-Hodgkin lymphoma]], | [[Non-Hodgkin lymphoma]], | ||
[[ovarian cancer ]], | [[ovarian cancer ]] , | ||
[[rhabdomyosarcoma]], | [[rhabdomyosarcoma]], | ||
[[sarcoma]], | [[sarcoma]], | ||
Line 132: | Line 146: | ||
[[thalidomide]], | [[thalidomide]], | ||
[[Richter's transformation|transformed lymphoma]], | [[Richter's transformation|transformed lymphoma]], | ||
[[Transitional cell carcinoma|urothelial cancer ]] | [[Transitional cell carcinoma|urothelial cancer]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Ophthalmologic''' | | '''Ophthalmologic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Overdose/Toxicity''' | | '''Overdose/Toxicity''' | ||
|bgcolor="Beige"| | | bgcolor="Beige" | | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Psychiatric''' | | '''Psychiatric''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Pulmonary''' | | '''Pulmonary''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Renal/Electrolyte''' | | '''Renal/Electrolyte''' | ||
|bgcolor="Beige"| | | bgcolor="Beige" | | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| | | bgcolor="Beige" | | ||
No underlying causes|- | No underlying causes|- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Sexual''' | | '''Sexual''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Trauma''' | | '''Trauma''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Urologic''' | | '''Urologic''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| No underlying causes | | bgcolor="Beige" | No underlying causes | ||
|- | |- | ||
|} | |} |
Latest revision as of 13:42, 7 September 2018
Tumor lysis syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Tumor lysis syndrome causes On the Web |
American Roentgen Ray Society Images of Tumor lysis syndrome causes |
Risk calculators and risk factors for Tumor lysis syndrome causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Nazia Fuad M.D.
Overview
Development of tumor lysis syndrome is the result of initiation of chemotherapy or radiotherapy in cancer patients. The most common causes of tumor lysis syndrome are Burkitt's lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia and chemotherapy including methotrexate. Sometimes it can occur spontaneously without administration of treatment primarily in patients with non-Hodgkin lymphoma (NHL) or acute leukemia.
Causes
Common Causes
The most common causes of tumor lysis syndrome are:[1][2]
- Burkitt's lymphoma
- Acute lymphoblastic leukemia
- Acute myeloid leukemia
- Chemotherapy including methotrexate
Less common causes
- Solid tumor
- Myeloma
- Chronic myeloid leukemia CML
- CLL chronic lymphocytic leukemia
- Hodgkin lymphoma
- Small lymphocytic lymphoma
- Marginal zone B cell
- MALT
- Nonblastoid mantle cell
- Cutaneous T cell
- Adult T-cell leukemia
Causes by Organ System
Cardiovascular | No underlying causes |
Chemical/Poisoning | No underlying causes |
Dental | No underlying causes |
Dermatologic | No underlying causes |
Drug Side Effect |
Bortezomib, Carfilzomib, Cytarabine, cytotoxic chemotherapy, Doxorubicin Hydrochloride etoposide, fludarabine, glucocorticoids, hydroxyurea, Ibrutinib, imatinib, lenalidomide , Nelarabine, Nilotinib, Ofatumumab, paclitaxel, Pralatrexate, rituximab, thalidomide, Vincristine sulfate liposome zoledronic acid |
Ear Nose Throat | No underlying causes |
Endocrine | No underlying causes |
Environmental | No underlying causes |
Gastroenterologic | No underlying causes |
Genetic | No underlying causes |
Hematologic | No underlying causes |
Iatrogenic | No underlying causes |
Infectious Disease | No underlying causes |
Musculoskeletal/Orthopedic | No underlying causes |
Neurologic | No underlying causes |
Nutritional/Metabolic | No underlying causes |
Obstetric/Gynecologic | No underlying causes |
Oncologic |
Acute lymphoblastic leukemia , acute myeloid leukemia, adult T-cell leukemia/lymphoma , anaplastic large cell lymphoma, breast cancer , Burkitt's lymphoma, chronic myeloid leukemia, diffuse large B-cell lymphoma, gastrointestinal stromal tumors, germ cell tumors , hepatoblastoma, hepatocellular carcinoma, hodgkin's disease, isolated plasmacytomas, mantle cell lymphoma, medulloblastoma, melanoma, metastatic colorectal cancer , multiple myeloma, neuroblastoma, Non-Hodgkin lymphoma, ovarian cancer , rhabdomyosarcoma, sarcoma, small cell lung cancer, squamous cell carcinoma of the vulva, thalidomide, transformed lymphoma, urothelial cancer |
Ophthalmologic | No underlying causes |
Overdose/Toxicity | |
Psychiatric | No underlying causes |
Pulmonary | No underlying causes |
Renal/Electrolyte | |
Rheumatology/Immunology/Allergy |
No underlying causes|- |
Sexual | No underlying causes |
Trauma | No underlying causes |
Urologic | No underlying causes |
Miscellaneous | No underlying causes |
Causes by Alphabetical Order
References
- ↑ "www.asn-online.org" (PDF).
- ↑ Howard SC, Jones DP, Pui CH (May 2011). "The tumor lysis syndrome". N. Engl. J. Med. 364 (19): 1844–54. doi:10.1056/NEJMra0904569. PMC 3437249. PMID 21561350.